title: [Surgical prospects for liver metastases].
abstract: The recent advances in liver surgery have made it possible to perform liver resections in an increasing number of patients with consequent improvement in the results. This coincides with an amplification of the indications to liver surgery for metastases. Besides the development of radiological procedures as applied to liver surgery and more effective chemotherapy protocols, the actual approach to patients with liver metastases is shared by three figures - the surgeon, the radiologist and the oncologist. Currently it has been shown that liver resections for metastases are possible with a meaningful increase of survival in the case of colorectal and neuroendocrine liver metastases and in selected cases of non-colorectal non-neuroendocrine metastases. From the technical point of view the most remarkable aspect is the possibility of expanding the criteria of resectability by means of liver resections in one or two steps associated with portal vein embolisation or ligation of a portal branch. It is also possible to perform iterative liver resections and liver transplantation in selected cases of neuroendocrine liver metastases.
authors.affiliation: Divisione di Chirurgia Digestiva Oncologica e dei Trapianti di Fegato Dipartimento di Chirurgia Oncologica, Istituto Regina Elena, Roma.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Vennarecci
authors.forename: Giuseppe Maria
authors.initials: GM
authors.lastname: Ettorre
authors.forename: Riccardo
authors.initials: R
authors.lastname: Lorusso
authors.forename: Roberto
authors.initials: R
authors.lastname: Santoro
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Visco
authors.forename: Eugenio
authors.initials: E
authors.lastname: Santoro
mesh_terms: D002404:Catheterization / Q000379:methods; D015179:Colorectal Neoplasms / Q000473:pathology*; D004621:Embolization, Therapeutic; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000601:surgery*; D018358:Neuroendocrine Tumors / Q000556:secondary* / Q000601:surgery*; D012086:Reoperation; D016019:Survival Analysis; D016896:Treatment Outcome